Literature DB >> 29279053

Unraveling the conundrum of asthma phenotypes and endotypes.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29279053      PMCID： PMC5743844          DOI： 10.2500/aap.2018.39.4112

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN： 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  15 in total

1.  Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.

Authors:  James Fox; Arthur B Vegh; Inmaculada Martinez-Saguer; Walter A Wuillemin; Jonathan Edelman; Debora Williams-Herman; Mikhail Rojavin; Tanja Rosenberg
Journal:  Allergy Asthma Proc       Date:  2017-05-01       Impact factor: 2.587

Review 2.  Chronic rhinosinusitis with nasal polyps in the elderly: Assessing current evidence.

Authors:  Gino Marioni; Claudia Zanotti; Giuseppe Brescia
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

Review 3.  A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Authors:  Eli O Meltzer; William E Berger
Journal:  Allergy Asthma Proc       Date:  2018-01-06       Impact factor: 2.587

4.  The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/fc epsilon RII) in patients with severe allergic asthma.

Authors:  Miri Assayag; Shabtai Moshel; Martin Kohan; Neville Berkman
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

5.  Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting.

Authors:  Brian Stone; Jill R Davis; Frank Trudo; Bradd Schiffman; Carlos Alzola; David Brown; Kathleen M Fox
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

6.  Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Authors:  Karsten Weller; Marcus Maurer; Moshe Fridman; Dylan Supina; Jennifer Schranz; Markus Magerl
Journal:  Allergy Asthma Proc       Date:  2017-01-16       Impact factor: 2.587

Review 7.  The dilemma of allergy to food additives.

Authors:  Sami L Bahna; Joshua G Burkhardt
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

8.  Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.

Authors:  H Henry Li; Avner Reshef; James W Baker; Joseph R Harper; Anurag Relan
Journal:  Allergy Asthma Proc       Date:  2017-09-05       Impact factor: 2.587

9.  Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.

Authors:  Marc A Riedl; William R Lumry; H Henry Li; Aleena Banerji; Jonathan A Bernstein; Murat Ba; Janne Bjrkander; Markus Magerl; Marcus Maurer; Kevin Rockich; Hongzi Chen; Jennifer Schranz
Journal:  Allergy Asthma Proc       Date:  2016-11       Impact factor: 2.587

10.  Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.

Authors:  Marc A Riedl; H Henry Li; Marco Cicardi; Joseph R Harper; Anurag Relan
Journal:  Allergy Asthma Proc       Date:  2017-09-13       Impact factor: 2.587
View more
  1 in total

1.  Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.

Authors:  Natalia Celejewska-Wójcik; Krzysztof Wójcik; Maria Ignacak-Popiel; Adam Ćmiel; Katarzyna Tyrak; Anna Gielicz; Aleksander Kania; Paweł Nastałek; Marek Sanak; Lucyna Mastalerz
Journal:  Allergy       Date:  2020-01-28       Impact factor: 13.146
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.